Age-Related Disability Outcomes After a First Demyelinating Event

Area of Science:

• Neurology
• Neuroimmunology
• Clinical Research

Background:

• Disability accumulation in multiple sclerosis (MS) can begin early.
• Aging is a significant factor in MS progression and disability.
• Early detection of MS progression is crucial for management.

Purpose of the Study:

• To investigate the prognostic impact of age at first demyelinating event (FDE) on MS progression.
• To analyze various disability outcomes in different age groups.
• To assess age-specific differences in inflammatory and neurodegenerative markers.

Main Methods:

• Prospective cohort study of 1,170 patients aged 18-50 years since 1994.
• Categorization into three age groups: 18-29, 30-39, and 40-50 years.
• Comparison of relapse-associated worsening, relapse rates, EDSS trajectories, and Cox regression analyses for multiple outcomes including PIRA and CDA.

Main Results:

• The 40-50 age group had higher relapse-associated worsening at FDE and greater annual EDSS increase.
• This older group showed lower risk for inflammatory outcomes (relapses, new lesions) but higher risk for confirmed disability accumulation (CDA) and progression independent of relapse activity (PIRA).
• Patient-reported outcomes related to function and well-being were more affected in the 40-50 group.

Conclusions:

• Patients experiencing FDE at 40-50 years present with less inflammatory disease activity compared to younger individuals.
• Despite lower inflammatory markers, older patients face a higher risk of neurodegenerative outcomes.
• Age is a critical determinant of MS disease course and disability accrual.